BRK-B vs CBOE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
CBOE exhibits a stable financial profile with a Piotroski F-Score of 4/9 and a strong balance sheet characterized by low debt/equity (0.31). While the stock is trading near its growth-based intrinsic value of $307.39, it is significantly overpriced relative to its defensive Graham Number of $107.29. Exceptional earnings growth (60.5% YoY) and a consistent track record of earnings beats are offset by a high PEG ratio (3.75) and bearish short-term signals. The convergence of a 'Hold' analyst consensus, bearish insider activity, and a weak technical trend suggests the stock is currently fully valued.
Compare Another Pair
Related Comparisons
BRK-B vs CBOE: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Cboe Global Markets, Inc. (CBOE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.